Public and private equity tycoons jointly investigated ST Traditional Chinese Medicine Glen and Hu Jianping appeared on the research list

According to Datayes! Pro, public and private equity tycoons jointly investigated ST National Medicine (International Medicine), Ceibea Fund Gülen, Shibei Investment Hu Jianping appeared on the research list, and the institution paid attention to the follow-up arrangements for the company's suspension and rectification, whether there would be major changes in fundamentals, the impact on this year's performance, and the time window for revoking risk warnings.

ST National Medical, recently received 142 institutional surveys, including 1 of the best private equity investment managers of New Fortune, the survey summary:

1. The recent medical incidents in the company's subordinate hospitals, the two hospitals under the company should collect all the receivables under the premise of meeting the epidemic prevention requirements, during which two accidents occurred due to the mechanical implementation of the relevant epidemic prevention policies. Sincerely accepted the handling opinions of the Xi'an Municipal Health Commission, and pursued the responsibility of the relevant responsible persons.

2. The high-tech hospital and the central hospital have entered the stage of suspension and rectification in accordance with the requirements of the relevant notice of the Municipal Health Commission, and the Shangluo International Medical Center Hospital has opened normal operations. At present, there are nearly 2,000 patients in the two hospitals, more than 700 high-tech hospitals, and more than 1,200 people in the central hospital, and the number of patients is about 1/2 of the past.

3. The overall construction progress of the International Medical Rehabilitation Hospital has not been affected, and the implementation and promotion of various work will be accelerated according to the original plan. The current impact of the event is a predictable short-term impact, and the company's long-term work deployment is accelerating accordingly.

4. The company has been implemented a risk warning, according to the requirements, the company will make a timely announcement after the hospital obtains the approval of the Xi'an Municipal Health Commission for follow-up consultation, and submit an application to the exchange at the same time as the announcement to revoke the risk warning. The time for the relevant risk warning is predictable, and it is now expected to be about three months.

5. In addition to other risk warnings, there is no risk of being implemented because of performance factors.

6. The suspension of three months will affect the company's performance, but according to the historical data of previous years, the revenue in the first quarter accounts for the smallest proportion of the annual revenue, and the impact on performance is controllable. According to historical experience, the climb speed after follow-up consultation is relatively fast.

7, the company's fundamentals have not changed significantly, and fixed costs will not change due to suspension. The salaries, depreciation and financial expenses of the existing personnel of the two hospitals total about 120 million yuan per month, and the depreciation accounts for a relatively large proportion. The company's cash flow is good. At present, the stock pledge rate of the company's major shareholders and their consistent actors is 40.28%, and the financing scale is small, and there is no stock pledge risk.